Release Date: 28/05/12 08:25 Summary: Change of Director's Interest Notice - Appendix 3Y Price Sensitive: No Download Document 2B Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%